Hydroxyethyl cellulose functionalised with maleimide groups as a new excipient with enhanced mucoadhesive properties

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved..

Hydroxyethylcellulose (HEC) is a non-ionic water-soluble polymer with poor mucoadhesive properties. The mucoadhesive properties of hydroxyethylcellulose can be improved by modifying it through conjugation with molecules containing maleimide groups. Maleimide groups interact with the thiol groups present in cysteine domains in the mucin via Michael addition reaction under physiological conditions to form a strong mucoadhesive bond. This will prolong the residence time of a dosage form containing this modified polymer and drug on mucosal surfaces. In this study HEC was modified by reaction with 4-bromophenyl maleimide in varying molar ratios and the successful synthesis was confirmed using 1H NMR and FTIR spectroscopies. The safety of the newly synthesised polymer derivatives was assessed with in vivo planaria assays and in vitro MTT assay utilising Caco-2 cell line. The synthesized maleimide-functionalised HEC solutions were sprayed onto blank tablets to develop a model dosage form. The physical properties and mucoadhesive behavior of these tablets were evaluated using a tensile test with sheep buccal mucosa. The maleimide-functionalised HEC exhibited superior mucoadhesive properties compared to unmodified HEC.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:642

Enthalten in:

International journal of pharmaceutics - 642(2023) vom: 25. Juli, Seite 123113

Sprache:

Englisch

Beteiligte Personen:

Buang, Fhataheya [VerfasserIn]
Fu, Manfei [VerfasserIn]
Chatzifragkou, Afroditi [VerfasserIn]
Amin, Mohd Cairul Iqbal Mohd [VerfasserIn]
Khutoryanskiy, Vitaliy V [VerfasserIn]

Links:

Volltext

Themen:

9004-34-6
9004-62-0
Cellulose
Excipients
Hydroxyethylcellulose
Journal Article
Maleimide
Maleimides
Mucoadhesion
Oral delivery
Polymers
Spray coated tablets
Tablets

Anmerkungen:

Date Completed 24.07.2023

Date Revised 24.07.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijpharm.2023.123113

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358029856